France

CORA 2023

Turin, Italie, 16-18 mars 2023 

ECCMID 2023

Copenhagen, 15 - 18 April 2023

Société Francophone du Diabète Congrès Annuel

Montpellier, March 21 -24, 2023

MENARINI ANNOUNCES AN EXCLUSIVE DISTRIBUTION AGREEMENT FOR BODITECH’S AFIAS-10 SYSTEM

FLORENCE, ITALY, April 19ᵗʰ 2023, A.Menarini Diagnostics S.r.l. (Menarini) is pleased to announce an exclusive distribution agreement for the AFIAS-10 System and IGRA-TB Assay (among others), building on several years of fruitful collaboration  with Boditech Med Inc. (Boditech)  in Italy. 

“A. MENARINI DIAGNOSTICS ANNOUNCES THE RELEASE OF THE PRIME-MDX PLATFORM”

FLORENCE, ITALY, May 22, 2023, A.Menarini Diagnostics S.r.l. (Menarini) is pleased to announce the commercial launch of its PRIME MDx platform: a sample-to-result, all-in-one, fully-automated molecular diagnostics platform for the processing of various testing portfolios through real-time PCR.

12345

Nos valeurs

4 valeurs qui ont donné vie à Menarini et façonné son histoire

LIRE LA SUITE »